JPRN-jRCTs051190120Recruiting未知
The multicenter clinical trial to investigate the safety and efficacy of FOLFOX therapy in gastrointestinal cancer patients undergoing hemodialysis
Manabu Muto0 sites15 target enrollmentStarted: March 11, 2020Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Sponsor
- Enrollment
- 15
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- ot applicable to <= 80age old (—)
- Sex
- All
Inclusion Criteria
- •1. Patients undergoing hemodialysis.
- •2. Patients diagnosed as gastrointestinal cancer.
- •3. Less than 80years old, and PS is 0-1.
- •4. Organ functions other than renal function are maintained.
- •5. Chemotherapy naive case.
- •6. The written consent can be obtained from patients.
Exclusion Criteria
- •1. Hyperammonemia within 14 days befere registration.
- •2. Patients with Grade 2 peripheral sensory neuropathy.
Investigators
Similar Trials
Recruiting
Not Applicable
The multicenter clinical trial to investigate the safety and efficacy of FOLFOX therapy in gastrointestinal cancer patients undergoing hemodialysisgastrointestinal cancerJPRN-UMIN000033322Kyoto University15
Completed
Not Applicable
A multi-centre clinical trial evaluating the safety and functionality of a medical imaging device for tissue review during breast-conserving surgery.Cancer - BreastBreast CancerACTRN12623000205639OncoRes Medical Pty Ltd30
Active, not recruiting
Not Applicable
An open multicenter clinical trial to evaluate the safety, tolerability and efficacy of Deferasirox (ICL670) in patients affected by Myelodysplastic syndrome and transfusional chronic hemosiderosis. - GIMEMA MDS 0306ow and intermediate I risk (IPSS score) Myelodysplastic syndrome and transfusion-induced hemosiderosis.MedDRA version: 9.1Level: LLTClassification code 10028533Term: Myelodysplastic syndromeEUCTR2006-006147-31-ITG.I.M.E.M.A. GRUPPO ITALIANO MALATTIE EMATOLOGICHE DELL'ADULTO
Not yet recruiting
Not Applicable
Comparative clinical study of eye drops in dry eye syndromeDiseases of the eye and adnexaKCT0004516Kangbuk Samsung Medical Center60
Active, not recruiting
Not Applicable
A multi-center, open-label trial to investigate the safety and tolerability of intravenous SPM 927 as replacement for oral SPM 927 in subjects with partial seizures with or without secondary generalization.partial seizures with or without secondary generalizationMedDRA version: 6.0Level: LLTClassification code 10034089EUCTR2004-002322-22-DESCHWARZ BIOSCIENCES Inc.160